Search

Your search keyword '"Kovalenko, S."' showing total 4,817 results

Search Constraints

Start Over You searched for: "Kovalenko, S." Remove constraint "Kovalenko, S."
4,817 results on '"Kovalenko, S."'

Search Results

1. Measurement of the intrinsic hadronic contamination in the NA64$-e$ high-purity $e^+/e^-$ beam at CERN

2. On the Role of LHC and HL-LHC in Constraining Flavor Changing Neutral Currents

3. Reconstruction of 400 GeV/c proton interactions with the SHiP-charm project

4. Geoportals in Solving the Problem of Natural Hazards Monitoring

7. Flavor changing interactions confronted with meson mixing and hadron colliders

8. Search for a New B-L Z' Gauge Boson with the NA64 Experiment at CERN

9. Search for a light muon-philic $Z^\prime$ with the NA64-$e$ experiment at CERN

10. Figure 4 from: Logoyda L, Piponski M, Kovalenko S, Dutchak O, Denefil O, Soroka Y, Pidruchna S, Popovych D, Susla O (2021) Method development for the quantitative determination of captopril from Caco-2 cell monolayers by using LC-MS/MS. Pharmacia 68(1): 61-67. https://doi.org/10.3897/pharmacia.68.e52077

11. Figure 3 from: Logoyda L, Piponski M, Kovalenko S, Dutchak O, Denefil O, Soroka Y, Pidruchna S, Popovych D, Susla O (2021) Method development for the quantitative determination of captopril from Caco-2 cell monolayers by using LC-MS/MS. Pharmacia 68(1): 61-67. https://doi.org/10.3897/pharmacia.68.e52077

14. Figure 6 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

15. Figure 3 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

17. Figure 2 from: Logoyda L, Piponski M, Kovalenko S, Dutchak O, Denefil O, Soroka Y, Pidruchna S, Popovych D, Susla O (2021) Method development for the quantitative determination of captopril from Caco-2 cell monolayers by using LC-MS/MS. Pharmacia 68(1): 61-67. https://doi.org/10.3897/pharmacia.68.e52077

18. Figure 4 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

19. Figure 1 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

21. Figure 2 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

22. Figure 5 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

24. Supplementary material 1 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

25. Figure 1 from: Logoyda L, Piponski M, Kovalenko S, Dutchak O, Denefil O, Soroka Y, Pidruchna S, Popovych D, Susla O (2021) Method development for the quantitative determination of captopril from Caco-2 cell monolayers by using LC-MS/MS. Pharmacia 68(1): 61-67. https://doi.org/10.3897/pharmacia.68.e52077

28. Constraining 3-3-1 Models at the LHC and Future Hadron Colliders

29. Status and initial physics performance studies of the MPD experiment at NICA

30. Lepton Phenomenology of Stueckelberg Portal to Dark Sector

31. Improved exclusion limit for light dark matter from $e^+e^-$ annihilation in NA64

32. Probing the explanation of the muon (g-2) anomaly and thermal light dark matter with the semi-visible dark photon channel

35. Search for pseudoscalar bosons decaying into $e^+e^-$ pairs in the NA64 experiment at the CERN SPS

37. Constraints on New Physics in the Electron g-2 from a Search for Invisible Decays of a Scalar, Pseudoscalar, Vector, and Axial Vector

38. Prediction of Natural Processes Using a Deep Neural Network Model

40. I. N. Kovalenkoʼs Scientific Works

41. Sensitivity of the SHiP experiment to dark photons decaying to a pair of charged particles

42. Hunting down the X17 boson at the CERN SPS

43. Ni-doped epitaxial graphene monolayer on the Ni(111) surface

44. Search for Axionlike and Scalar Particles with the NA64 Experiment

45. Vector-Like Leptons and Inert Scalar Triplet: Lepton Flavor Violation, $g-2$ and Collider Searches

46. SND@LHC

47. Room temperature propylene dehydrogenation and linear atomic chain formation on Ni(111)

48. Improved limits on a hypothetical X(16.7) boson and a dark photon decaying into $e^+e^-$ pairs

50. Quark condensate seesaw mechanism for neutrino mass

Catalog

Books, media, physical & digital resources